ViroGates A/S (CPH:VIRO)

Market Cap	61.88M
Revenue (ttm)	7.14M
Net Income (ttm)	-14.35M
Shares Out	7.73M
EPS (ttm)	-2.15
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	5,881
Open	7.45
Previous Close	8.00
Day's Range	7.35 - 7.45
52-Week Range	5.20 - 31.00
Beta	0.84
RSI	36.65
Earnings Date	Mar 20, 2025

About ViroGates

ViroGates A/S, an in vitro diagnostics company, develops and markets prognostic products for the healthcare sector. It offers suPARnostic, a proprietary biomarker used in hospital emergency services to support the clinical decision on hospitalization or discharge of acute patients and to identify high-risk sepsis patients at an early stage, as well as used for the prognosis of lifestyle-related diseases, such as cardiovascular disease, type 2 diabetes, and cancer; and for the assessment of longevity and biological age in a non-hospital setting....

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 10
• Stock Exchange: Copenhagen Stock Exchange
• Ticker Symbol: VIRO

Financial Performance

In 2024, ViroGates's revenue was 7.14 million, an increase of 2.22% compared to the previous year's 6.99 million. Losses were -14.35 million, 18.6% more than in 2023.